To amend the Controlled Substances Act to require warning labels for prescription opioids, and for other purposes.

Sponsor

Actions

June 26, 2019

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.Action By: Committee on the Judiciary

May 14, 2019

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.Action By: House of Representatives